Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Harold L. Brooks is active.

Publication


Featured researches published by Harold L. Brooks.


American Journal of Cardiology | 1978

Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy: II. In-Hospital experience and initial follow-up results in patients with one, two and three vessel disease

Richard O. Russell; Roger E. Moraski; Nicholas T. Kouchoukos; Robert B. Karp; John A. Mantle; William J. Rogers; Charles E. Rackley; Leon Resnekov; Raul E. Falicov; Jafar Al-Sadir; Harold L. Brooks; Constantine E. Anagnostopoulos; John J. Lamberti; Michael J. Wolk; Thomas Killip; Robert A. Rosati; H.N. Oldham; Galen S. Wagner; Robert H. Peter; C.R. Conti; R.C. Curry; George R. Daicoff; Lewis C. Becker; G. Plotnick; Vincent L. Gott; Robert K. Brawley; James S. Donahoo; Richard S. Ross; Adolph M. Hutter; Roman W. DeSanctis

Abstract A prospective randomized study comparing intensive medical therapy with urgent coronary bypass surgery for the acute management of patients with unstable angina pectoris was carried out by nine cooperating medical centers under the auspices of the National Heart, Lung, and Blood Institute. Between 1972 and 1976, a total of 288 patients were entered into the study. All patients had transient S-T or T wave changes, or both, in the electrocardiogram during pain; 90 percent had pain at rest in the hospital, and 76 percent had multivessel coronary disease. The medically and surgically treated patients were comparable with respect to clinical, electrocardiographic and angiographic characteristics and left ventricular function. During the total study period, the hospital mortality rate was 5 percent in the surgical group and 3 percent in the medical group (difference not significant). The rate of in-hospital myocardial infarction was 17 and 8 percent in the respective groups (P In the 1st year after hospital discharge class III or IV angina (New York Heart Association criteria) was more common in medically than in surgically treated patients with one vessel disease (22 percent versus 3 percent, P The results indicate that patients with unstable angina pectoris can be managed acutely with intensive medical therapy, including the administration of propranolol and long-acting nitrates in pharmacologic doses, with adequate control of pain in most patients and no increase in early mortality or myocardial infarction rates. Later, elective surgery can be performed with a low risk and good clinical results if the patients angina fails to respond to intensive medical therapy.


Annals of Internal Medicine | 1971

Diagnostic Sensitivity of Laboratory Findings in Acute Pulmonary Embolism

Murrill M. Szucs; Harold L. Brooks; William Grossman; John S. Banas; Steven G. Meister; Lewis Dexter; James E. Dalen

Abstract Many different laboratory tests have been used to screen patients for pulmonary embolism. The sensitivity of certain laboratory tests was assessed in a prospective study of 50 patients wit...


American Journal of Cardiology | 1977

TQ-ST segment mapping: Critical review and analysis of current concepts

Roger P. Holland; Harold L. Brooks

Controversy and confusion surround many aspects of TQ-ST segment mapping today. Technical standards pertaining to the recording and measurement of the TQ-ST deflection have not been uniformly established nor has the correlative value of the deflection as an indicator of myocardial injury been clearly ascertained. The TQ-ST deflection is believed to originate primarily although not exclusively as a result of extracellular potassium accumulation in the ischemic region and subsequent establishment of a transmembrane potential gradient during diastole and systole at the ischemic boundary. Nonspatial factors (including electrolytes, antiarrhythmic agents, heart rate) influence the TQ-ST deflection by altering this gradient. Spatial factors (including ischemic area and shape, electrode location) alter the relative position of the ischemic boundary to the electrode site and as such can be analyzed with the solid angle theorem. Further study of the complex behavior of the TQ-ST segment deflection, particularly in the presence of pharmacologic intervention, is necessary before mapping techniques can be used reliably in clinical studies designed to quantitate and modify ischemic damage.


Anesthesiology | 1969

The hemodynamic and respiratory effects of diazepam (Valium).

James E. Dalen; Gerald L. Evans; John S. Banas; Harold L. Brooks; John A. Paraskos; Lewis Dexter

Diazepam, 5–10 rag, was given intravenously to treat anxiety occurring during cardiac catheterization in 15 patients. Anxiety was effectively relieved in 11 patients. Hemodynamic and ventilatory parameters were assessed before, and ten and 30 minutes after diazepam. The cardiac index decreased significantly in only three patients, each of whom had a control cardiac index in the high-normal range. No significant changes occurred in patients whose control cardiac indexes were below normal. Systolic blood pressure decreased by more than 10 mm Hg in eight patients. Pulmonary arterial pressure, heart rate, stroke volume and pulmonary and systemic resistance did not change significantly. Hypoventilation occurred in all patients. Ten minutes after diazepam minute ventilation had decreased by 28 per cent and tidal volume by 23 per cent. Paco2 increased by 5 mm Hg and Pao2 decreased by 10 mm Hg. The observed changes in blood pressure and ventilation were without clinical correlates and did not require therapy.


American Journal of Cardiology | 1976

Unstable angina pectoris: National cooperative study group to compare medical and surgical therapy

Richard O. Russell; Roger E. Moraski; Nicholas T. Kouchoukos; Robert B. Karp; John A. Mantle; William J. Rogers; Charles E. Rackley; Leon Resnekov; Raul E. Falicov; Jafar Al-Sadir; Harold L. Brooks; Constantine E. Anagnostopoulos; John J. Lamberti; Michael J. Wolk; Thomas Killip; Robert A. Rosati; H.N. Oldham; Galen S. Wagner; Robert H. Peter; C.R. Conti; R.C. Curry; George R. Daicoff; Lewis C. Becker; G. Plotnick; Vincent L. Gott; Robert K. Brawley; James S. Donahoo; Richard S. Ross; Adolph M. Hutter; Roman W. DeSanctis

A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the eithical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.Abstract A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the ethical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.


The American Journal of Medicine | 1989

Should the elderly be resuscitated following out-of-hospital cardiac arrest?

Donald D. Tresch; Ranjan K. Thakur; Raymond G. Hoffmann; David W Olson; Harold L. Brooks

PURPOSE Elderly and younger patients who were successfully resuscitated and hospitalized following out-of-hospital cardiac arrest were studied to determine if there was a significant difference in hospital course and long-term survival between the two groups. PATIENTS AND METHODS The study consisted of 214 consecutive patients, divided into two age groups: elderly (more than 70 years, n = 112) and younger (less than 70 years, n = 102). Hospital charts and paramedic run data were retrospectively reviewed for each patient and findings were compared between the two age groups. RESULTS Prior to cardiac arrest, 47 of 112 (42 percent) elderly patients had a history of heart failure, compared with 19 of 102 (18 percent) younger patients, and were more commonly taking digitalis (51 percent versus 29 percent) and diuretics (47 percent versus 26 percent). Younger patients, however, more often had an acute myocardial infarction at the time of the cardiac arrest (33 percent versus 16 percent). At the time of cardiac arrest, 83 percent of younger patients demonstrated ventricular fibrillation, compared with 71 percent of the elderly. In contrast, electromechanical dissociation was five times more common in the elderly patients. Although hospital deaths were more common in the elderly (71 percent versus 53 percent), the length of hospitalization and stay in intensive care units were not significantly different between the age groups. The number of neurologic deaths was similar in both age groups, as were residual neurologic impairments. Only five elderly patients and six younger patients required placement in extended-care facilities. Calculated long-term survival curves demonstrated similar survival in both age groups, with approximately 65 percent of hospital survivors alive at 24 months after hospital discharge. CONCLUSION Resuscitation of elderly patients in whom out-of-hospital cardiac arrest occurs is reasonable and appropriate, according to the findings of this study. Even though elderly patients are more likely than younger patients to die during hospitalization, the hospital stay of the elderly is not longer, the elderly do not have more residual neurologic impairments, and survival after hospital discharge is similar to that in younger patients.


American Journal of Cardiology | 1976

Unstable angina pectoris: National cooperative study group to compare medical and surgical therapy. I. Report of protocol and patient population

Richard O. Russell; Roger E. Moraski; Nicholas T. Kouchoukos; Robert B. Karp; John A. Mantle; Charles E. Rackley; Leon Resnekov; Raul E. Falicov; Jafar Al-Sadir; Harold L. Brooks; Constantine E. Anagnostopoulos; John J. Lamberti; Michael J. Wolk; Thomas Killip; Paul A. Ebert; Robert A. Rosati; N. Oldham; B. Mittler; Robert H. Peter; C. R. Conti; Richard S. Ross; Robert K. Brawley; G. Plotnick; Vincent L. Gott; James S. Donahoo; Lewis C. Becker; Adolph M. Hutter; Roman W. DeSanctis; Herman K. Gold; Robert C. Leinbach

A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the eithical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.Abstract A preliminary report is presented of a prospective randomized trial conducted by eight cooperative institutions under the auspices of the National Heart and Lung Institute to compare the effectiveness of medical and surgical therapy in the management of the acute stages of unstable angina pectoris. To date 150 patients have been included in the randomized trial, 80 assigned to medical and 70 to surgical therapy; the clinical presentation, coronary arterial anatomy and left ventricular function in the two groups are similar. Some physicians have been reluctant to prescribe medical or surgical therapy by a random process, and the ethical basis of the trial has been questioned. Since there are no hard data regarding the natural history and outcome of therapy for unstable angina pectoris, randomization appears to provide a rational way of selecting therapy. Furthermore, subsets of patients at high risk may emerge during the process of randomization. The design of this randomized trial is compared with that of another reported trial. Thus far, the study has shown that it is possible to conduct a randomized trial in patients with unstable angina pectoris, and that the medical and surgical groups have been similar in relation to the variables examined. The group as a whole presented with severe angina pectoris, either as a crescendo pattern or as new onset of angina at rest, and 84 percent had recurrence of pain while in the coronary care unit and receiving vigorous medical therapy. It is anticipated that sufficient patients will have been entered into the trial within the next 12 months to determine whether medical or surgical therapy is superior in the acute stages of unstable angina pectoris.


Annals of Internal Medicine | 1971

Effects of beta blockade on the peripheral manifestations of thyrotoxicosis.

William Grossman; Noel I. Robin; Lewis W. Johnson; Harold L. Brooks; Herbert A. Selenkow; Lewis Dexter

Abstract A double-blind controlled study was conducted in 10 patients to determine the effects of beta adrenergic blockade with sotalol on the peripheral manifestations of thyrotoxicosis. After sot...


Journal of Pharmacological Methods | 1981

Determination of Experimental myocardial infarct size

David C. Warltier; Mark G. Zyvoloski; Garrett J. Gross; Harold F. Hardman; Harold L. Brooks

Myocardial infarction was produced in anesthetized dogs by a 2-hr occlusion and 30-min reperfusion of the left anterior descending cornary artery. A balloon-reservoir perfusion system was used for reperfusion and delineation of perfusion bed size (area at risk) with Patent blue dye. Infarct mass was determined by a histochemical staining technique with triphenyl tetrazolium chloride. Regional myocardial perfusion in infarcted, ischemic, and normal regions was measured with radioactive microspheres. Infarct size was 8.5 +/- 1.6 g and accounted for irreversible damage in 9.2 +/- 1.9% and 32.5 +/- 4.8% of the left ventricle and area at risk, respectively. Regional myocardial blood flow within infarcted regions was constant over the 2-hr occlusion period (0.10 +/- 0.03 to 0.11 +/- 0.02 ml/min/g). Following reperfusion, these areas demonstrated significantly lower flow than did normal regions, Ischemic but noninfarcted tissue also had no change in flow over the occlusion period, but flow returned to normal following reperfusion. This study describes reliable methodology for production and determination of infarct size with simultaneous measurement of several factors involved in the relative extent of irreversible tissue damage.


American Heart Journal | 1987

Time course of recovery of “stunned” myocardium following variable periods of ischemia in conscious and anesthetized dogs☆

Kevin C. Preuss; Garrett J. Gross; Harold L. Brooks; David C. Warltier

Persistence of regional contractile dysfunction after restoration of blood flow to transiently ischemic myocardium has been well described. To date, most studies have been performed in anesthetized animals. The present investigation compared the time course of recovery of regional segment shortening (percentage of segment shortening) in anesthetized versus conscious dogs subjected to a brief period of total occlusion of the left anterior descending coronary artery. Periods of occlusion lasting 5, 10, and 15 minutes were followed by 3 hours of reperfusion. Dogs anesthetized with sodium pentobarbital (30 mg/kg intravenously) had a significantly higher heart rate and blood pressure and lower dP/dt than conscious dogs. Coronary artery occlusion resulted in similar degrees of regional dyskinesis or akinesis, indicative of severe myocardial ischemia, in all experiments. During reperfusion, a gradual return of contractile function toward baseline was observed. At the end of the first 15 minutes of reflow, dogs subjected to 5 minutes of coronary occlusion demonstrated approximately 70% of control segment shortening in the previously ischemic zone. Animals subjected to 10- and 15-minute periods of coronary artery occlusion showed approximately 60% and 40% of control segment shortening at the same time point, respectively. The remainder of the 3-hour reperfusion period was characterized by a more gradual recovery of regional segment function. No differences were observed between anesthetized and conscious animals. It is concluded that the time course of functional recovery of postischemic reperfused myocardium is directly related to the duration of coronary occlusion and is similar in conscious and anesthetized dogs.

Collaboration


Dive into the Harold L. Brooks's collaboration.

Top Co-Authors

Avatar

David C. Warltier

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Garrett J. Gross

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Donald D. Tresch

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

G. J. Gross

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Mark G. Zyvoloski

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kevin C. Preuss

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Michael H. Keelan

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Dermot Kenny

Royal College of Surgeons in Ireland

View shared research outputs
Researchain Logo
Decentralizing Knowledge